NO973531D0 - Use of melatonin for the treatment of patients suffering from drug addiction - Google Patents

Use of melatonin for the treatment of patients suffering from drug addiction

Info

Publication number: NO973531D0
Authority: NO; Norway
Prior art keywords: melatonin; treatment; patients suffering; drug addiction; addiction
Prior art date: 1995-02-01

Application number

NO973531A

Other languages

Norwegian (no)

Other versions

NO312814B1 (en

NO973531L (en

Inventor

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-01

Filing date

1997-07-31

Publication date

1997-07-31

1995-02-01 Priority claimed from US08/381,535 external-priority patent/US6469044B1/en

1997-07-31 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

1997-07-31 Publication of NO973531D0 publication Critical patent/NO973531D0/en

1997-09-30 Publication of NO973531L publication Critical patent/NO973531L/en

2002-07-08 Publication of NO312814B1 publication Critical patent/NO312814B1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO19973531A 1995-02-01 1997-07-31 Use of melatonin in the manufacture of a drug for the treatment of patients suffering from drug dependence NO312814B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/381,535 US6469044B1 (en)	1995-02-01	1995-02-01	Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en)	1995-02-01	1995-06-06	Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en)	1995-02-01	1996-01-29	Use of melatonin for treating patients suffering from drug addiction

Publications (3)

Publication Number	Publication Date
NO973531D0 true NO973531D0 (en)	1997-07-31
NO973531L NO973531L (en)	1997-09-30
NO312814B1 NO312814B1 (en)	2002-07-08

Family

ID=26140195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19973531A NO312814B1 (en)	1995-02-01	1997-07-31	Use of melatonin in the manufacture of a drug for the treatment of patients suffering from drug dependence

Country Status (22)

Country	Link
JP (1)	JP4516159B2 (en)
CN (1)	CN1083263C (en)
AT (1)	AT408188B (en)
AU (1)	AU695366B2 (en)
BG (1)	BG62876B1 (en)
BR (1)	BR9607169A (en)
CZ (1)	CZ291349B6 (en)
DK (1)	DK176081B1 (en)
EE (1)	EE03384B1 (en)
FI (1)	FI119586B (en)
IS (1)	IS1980B (en)
LU (1)	LU90118B1 (en)
LV (1)	LV11940B (en)
MD (1)	MD1716C2 (en)
NO (1)	NO312814B1 (en)
NZ (1)	NZ298878A (en)
PL (1)	PL183148B1 (en)
SI (1)	SI9620022A (en)
SK (1)	SK284521B6 (en)
TR (1)	TR199700723T1 (en)
TW (1)	TW483757B (en)
WO (1)	WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE359072T1 (en)	2000-01-05	2007-05-15	Neurim Pharma 1991	METHOD AND COMPOSITION FOR TREATING RESISTANCE TO ANTIHYPERTENSIVE DRUGS AND RELATED CONDITIONS
IL149377A (en) *	2002-04-28	2012-10-31	Neurim Pharma 1991	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en)	2003-04-29	2015-09-01	Neurim Pharmaceuticals (1991) Ltd.	Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en)	2003-04-29	2013-12-31	Neurim Pharma 1991	Composition for treating insomnia
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
RU2650647C2 (en)	2012-01-26	2018-04-16	Ванда Фармасьютиклз Инк.	Treatment of circadian rhythm disorders
BR112015014619A2 (en)	2012-12-18	2017-07-11	Vanda Pharmaceuticals Inc	treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
ES3009413T3 (en) *	2016-10-31	2025-03-26	Neurim Pharma 1991	Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0518468T3 (en) *	1991-05-09	2000-01-31	Neurim Pharma 1991	Melatonin-containing compositions
IT1251544B (en) *	1991-05-13	1995-05-17	Gabriele Biella	PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

1996
- 1996-01-29 EE EE9700166A patent/EE03384B1/en not_active IP Right Cessation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/en not_active Expired - Lifetime
- 1996-01-29 CN CN96191750A patent/CN1083263C/en not_active Expired - Lifetime
- 1996-01-29 PL PL96321630A patent/PL183148B1/en unknown
- 1996-01-29 BR BR9607169A patent/BR9607169A/en not_active Application Discontinuation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/en unknown
- 1996-01-29 MD MD97-0254A patent/MD1716C2/en not_active IP Right Cessation
- 1996-01-29 SI SI9620022A patent/SI9620022A/en not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/en not_active IP Right Cessation
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/en not_active IP Right Cessation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/en unknown
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 AT AT0901396A patent/AT408188B/en not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/en not_active IP Right Cessation
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/en unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/en not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/en unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/en not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/en not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/en active

Also Published As

Publication number	Publication date
NZ298878A (en)	1999-05-28
TW483757B (en)	2002-04-21
MD970254A (en)	1999-05-31
PL183148B1 (en)	2002-05-31
AU695366B2 (en)	1998-08-13
LV11940B (en)	1998-05-20
MX9705856A (en)	1998-07-31
MD1716B2 (en)	2001-08-31
DK176081B1 (en)	2006-04-18
PL321630A1 (en)	1997-12-08
FI119586B (en)	2009-01-15
SK284521B6 (en)	2005-05-05
DK89697A (en)	1997-07-30
AT408188B (en)	2001-09-25
CN1172431A (en)	1998-02-04
SK103097A3 (en)	1998-01-14
IS1980B (en)	2005-01-14
AU4457496A (en)	1996-08-21
JP4516159B2 (en)	2010-08-04
FI973185L (en)	1997-09-30
EE03384B1 (en)	2001-04-16
WO1996023496A1 (en)	1996-08-08
BG101803A (en)	1998-04-30
LV11940A (en)	1998-01-20
LU90118B1 (en)	1997-11-13
ATA901396A (en)	2001-02-15
TR199700723T1 (en)	1998-02-21
FI973185A0 (en)	1997-07-31
CN1083263C (en)	2002-04-24
CZ291349B6 (en)	2003-02-12
JPH10513177A (en)	1998-12-15
BR9607169A (en)	1997-11-11
EE9700166A (en)	1998-02-16
BG62876B1 (en)	2000-10-31
CZ240597A3 (en)	1998-01-14
NO312814B1 (en)	2002-07-08
SI9620022A (en)	1998-10-31
NO973531L (en)	1997-09-30
IS4532A (en)	1997-07-25
MD1716C2 (en)	2002-02-28

Publication	Publication Date	Title
NO976063D0 (en)	1997-12-23	Procedure for the treatment of diabetes
NO965377L (en)	1997-02-12	Indolinone compounds for the treatment of diseases
NO982172D0 (en)	1998-05-13	Use of epinastine for the treatment of pain
CY2007001I1 (en)	2009-11-04	MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
FI952721A7 (en)	1995-12-04	Substance for the treatment of hepatobiliary diseases
LT97135A (en)	1997-12-29	Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction
DE69620691D1 (en)	2002-05-23	Therapeutic agent for the treatment of hypercholesterolemia
NO973531D0 (en)	1997-07-31	Use of melatonin for the treatment of patients suffering from drug addiction
NO20003229D0 (en)	2000-06-21	Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases
NO975545D0 (en)	1997-12-02	Cell line that produces analgesic compounds for the treatment of pain
FI973023L (en)	1997-07-16	Combined therapeutic treatment of hypertrophic disorders
NO975660D0 (en)	1997-12-05	Use of benzimidazoles for the manufacture of a drug for the treatment of liver chemistry
IS4528A (en)	1997-07-21	Bicyclic derivatives of isothio urea useful therapeutic treatment
NO995231D0 (en)	1999-10-26	Therapeutic treatment of skin disorders
FI971527A7 (en)	1997-04-11	Use of indole derivatives for the treatment of various diseases
HUP9903348A3 (en)	2000-11-28	Transdermal therapeutic system (tts) for administering active substances for the teratment of drug dependency or drug addiction
NO20012106D0 (en)	2001-04-27	Drug for the treatment of bone pathobolism
NO973081D0 (en)	1997-07-02	Procedure for the Treatment of Chronic Progressive Vascular Diseases
NO994258L (en)	1999-11-02	Use of levobupivacaine for the treatment of facial migraines
DK0879054T3 (en)	2008-04-07	Use of pyrrolidione derivatives for the manufacture of drugs for the treatment of drug addiction
NO20014812D0 (en)	2001-10-03	Method of Providing Cosmetic / Medical Therapy
NO982562D0 (en)	1998-06-04	Composition for the treatment of pain
NO973366D0 (en)	1997-07-21	Procedure for the treatment of multiple sclerosis
DE69840432D1 (en)	2009-02-26	MEDICAMENT FOR THE TREATMENT OF EYES
NO974529D0 (en)	1997-09-30	Device for the delivery of alfuzosin through the skin

Legal Events

Date	Code	Title	Description
2016-02-08	MK1K	Patent expired